CASP3 and neoplasm: Therefore, Zhou et al. [25] proposed that “therapeutic targeting of caspase-3 may not only increase the sensitivity of cancer cells to chemotherapy and radiotherapy, but also inhibit cancer cell invasion and metastasis.” Several previous reports with different tumor models [28,29,30,31] and with cancer patients [24,32] have led to a similar conclusion.